Abstract
I-123 metaiodobenzylguanidine (I-123 MIBG) scintigraphy is known for its high specificity in detecting pheochromocytoma and other tumors of neural crest origin. In this rare case report, we describe a definite adrenocortical adenoma that demonstrated false-positive uptake at I-123 MIBG scintigraphy and a remarkable accumulation of 75-SE-6-beta-selenomethyl-norcholesterol.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Beierwaltes W.H. Update on basic research and clinical experience with metaiodobenzylguanidine. Med. Pediat. Oncol. 15: 163, 1987.
Nakajo M., Shapiro B, Sisson J.C., Swanson D.P., Beierwaltes W.H. Salivary gland accumulation of meta-l-131-iodobenzylguanidine. J. Nucl. Med. 25: 2, 1984.
Nakajo M., Shapiro B, Copp J., Kalff V., Gross M.D., Sisson J.C., Beierwaltes W.H. The normal and abnormal distribution of the adrenomedullary imaging agent l-131-iodobenzylguanidine (l-131 MIBG) in man; evaluation of scintigraphy. J. Nucl. Med. 24: 672, 1983.
Sisson J., Wieland D. Radiolabeled meta-iodobenzylguanidine: pharmacology and clinical studies. Am. J. Physiol. Imaging 1: 96, 1986.
Hanson M.W., Feldman J.M., Beam C.A., Leight G.S., Coleman R.E. Iodine-131-labeled metaiodobenzylguanidine scintigraphy and biochemical analysis in suspected pheochromocytoma. Arch. Intern. Med. 151: 1397, 1991.
Mozley P.D., Kim C.K., Mohsin J., Jatlow A., Gossfield III E., Alavi A. The efficacy of iodine-123-MIBG as a screening test for pheochromocytoma. J. Nucl. Med. 35: 1138, 1994.
Ackery D.M., Tippett P.A., Condon B.R., Sutton H.E., Wyeth P. New approach to the localization of pheochromocytoma; imaging with lodine-131- metaiodobenzylguanidine. Br. Med. J. 288: 1587, 1984.
Bravo E.L., Gifford R.W. Pheochromocytoma: diagnosis, localization and management. N. Engl. J. Med. 311: 1298, 1984.
Chatal F., Charbonnel B. Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma. J. Clin. Endocrinol. Metab. 61: 769, 1985.
Velchik M.G., Alavi A., Kressel H.Y., Engelman K. Localization of pheochromocytoma: MIBG, CT and MRI correlation. J. Nucl. Med. 30: 328, 1989.
Letizia C., Scavo D. Meta-iodobenzylguanidine seen in the diagnosis of pathologic conditions of the adrenal medulla: pheochromocytoma. Arch. Intern. Med. 150: 1541, 1990.
Shapiro B., Copp J.E., Sisson J.C., Eyre P.L., Wallis J., Beierwaltes W.H. Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experiences in 400 cases. J. Nucl. Med. 26: 576, 1985.
Shapiro B. Summary, conclusions and future directions of 131-l-metaiodobenzylguanidine therapy in the treatment of neural crest tumors. J. Nucl. Biol. Med. 35: 357, 1993.
Jacobs A., Lenoir P., Delree M., Ramet J., Piepsz A. Unusual 99m-TC-MDP and 123-MIBG images in focal pyelonephritis. Clin. Nucl. Med. 15: 821, 1990.
Hanson M., Feldman J., Beam C., Leight G., Coleman R. Iodine-131-labeled metaiodobenzylguanidine scintigraphy and biochemical analysis in suspected pheochromocytoma. Arch. Intern. Med. 151: 1397, 1991.
Feggi L., Liberti E., Pansini G., Transforini G., Prandini N., Ambrosio M., D’urso A., Faggioli R. Pitfalls in scintigraphic detection of neuroendocrine tumors. Eur. J. Nucl. Med. 19: 214, 1992.
Gallar P., Qliet A., Hernandez E., Vigil A., Ortege O. Renal failure as a cause of false positive results on metaiodobenzylguanidine scan. Nephrol. Dial. Transplant. 481 (Letter), 1993.
Bathmann J., Neumann H., Sigmund G., Moser E. False-positive diagnosis of a pheochromocytoma with 1–123 metaiodobenzylguanidine. Clin. Nucl. Med. 19: 221, 1994.
Krubsack A., Arnaut M., Hagen T., Zielonka J., Choi H., Akhtar R., Schulte W. Zona fasciculata cortical adenoma and adrenal medullary hyperplasia in MEN II patient: unique concurrent presentation. Clin. Nucl. Med. 13: 730, 1988.
Home T., Glaser B., Krausz Y., Rubinger D., Britton K.E. Unusual causes of 1–131-metaiodobenzylguanidine uptake in non-neural crest tissue. Clin. Nucl. Med. 16: 239, 1991.
Sone H., Okuda Y., Nakamura Y., Ishikawa N., Yamaoka T., Odawara M., Matsushima T., Kawai K, Yamashita K. Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma: a false-positive case of adrenocortical adenoma and literature review. Horm. Res. 46: 138, 1996.
Houghton A., Clarke S., Jourdan M. False-positive diagnosis of adrenal pheochromocytoma on metaiodobenzylguanidine (MIBG) scan. Br. J. Clin. Pharmacol. 44: 411, 1990.
Alasabeh R., Mazoujian G., Goates J., Medeiros J., Weiss L.M. Adrenal cortical tumors clinically mimicking pheochromocytoma. Am. J. Clin. Pathol. 104: 382, 1995.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Letizia, C., De Toma, G., Massa, R. et al. False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan. J Endocrinol Invest 21, 779–783 (1998). https://doi.org/10.1007/BF03348046
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348046